Gender disparity in sexual health options for women: Experts call on pharma and drug regulators to address
In 2015 Comment in the prestigious medical journal Lancet Diabetes & Endocrinology by two of the world’s leading female sexual health specialists, Prof. … Continue reading
Menopause specialists warn against dangers of “bioidentical hormones”
On Monday 15th July 2019 in a comprehensive interview on the Life Matters program (ABC Radio National) two of Australia’s premier menopause specialists, Dr Elizabeth Farrell and … Continue reading
BBC Menopause and testosterone replacement therapy
Over 900 specialist menopause physicians from around the world attended The European Menopause and Andropause Society conference held in Berlin on 15-17th May 2019. Numerous … Continue reading
BBC Menopause and testosterone replacement therapy
Over 900 specialist menopause physicians from around the world attended The European Menopause and Andropause Society conference held in Berlin on 15-17th May 2019. Numerous … Continue reading
Testosterone replacement in menopause – BMS Toolkit for Clinicians
The British Menopause Society has this month released a Tools for Clinicals publication entitled Testosterone replacement in menopause. Authored by Mr Nick Panay, Consultant Gynaecologist, … Continue reading
Hypoactive sexual desire disorder (HSDD) re-defined
In late 2018 the World Health Organisation (WHO) released an update to The International Classification of Disease (ICD). ICD is a system of medical coding created … Continue reading
Effects of testosterone therapy in women – new systematic review and meta-analysis
It has been over a decade since the last systematic review and meta-analysis on the effects of testosterone for women was conducted as an … Continue reading
Hypoactive Sexual Desire Disorder (HSDD) re-defined
In late 2018 the World Health Organisation (WHO) released an update to The International Classification of Disease (ICD). ICD is a system of medical coding created … Continue reading
Axiron® discontinued – Upgrade to AndroForte® 5
Axiron® discontinued – Upgrade to AndroForte® 5 Axiron 2% testosterone solution has been discontinued in Australia effective 4th December 2017 after Lilly terminated its … Continue reading
FDA acknowledges there is a medical need for treating female sexual dysfunction
In late October 2016 the US FDA released draft guidance for Industry on Low Sexual Interest, Desire, and/or Arousal in Women: Developing Drugs for Treatment. This document states ” … Continue reading